Are There Therapeutic Implications Related to smpd1 in Toxicology?
Given its central role in cellular stress responses, the smpd1 gene is a potential therapeutic target. Modulating ASM activity could offer a strategy to mitigate the effects of toxic exposures and treat diseases associated with sphingolipid imbalances. Research is ongoing to develop ASM inhibitors or activators as potential therapies for conditions linked to excessive ceramide production or accumulation.
